Open Access

Zerumbone suppresses the potential of growth and metastasis in hepatoma HepG2 cells via the MAPK signaling pathway

  • Authors:
    • Tao Lv
    • Wenjing Zhang
    • Xiaoli Han
  • View Affiliations

  • Published online on: March 23, 2018     https://doi.org/10.3892/ol.2018.8335
  • Pages: 7603-7610
  • Copyright: © Lv et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Zerumbone is an active component of Zingiber zerumbet (L.) Smith and can perform a diverse range of antitumor activities. However, the underlying molecular mechanisms of zerumbone action have not yet been elucidated. The aim of the present study was to investigate the antitumor effects, and the associated molecular mechanisms, of zerumbone in hepatoma HepG2 cells. Treatment with zerumbone markedly induced apoptosis in hepatoma HepG2 cells and suppressed their invasion and metastasis in a dose‑dependent manner. Further investigation revealed that treatment with zerumbone led to the dose‑dependent induction of apoptosis and cell cycle arrest at G2/M phase in cancer cells. Zerumbone treatment led to the increased expression of p27, cytochrome c, caspase‑3 and‑9, and Bcl‑2‑associated X expression, but the decreased expression of cyclin‑dependent kinase 1, cyclin B1, B‑cell lymphoma‑2, focal adhesion kinase, Ras homolog gene family, member A, Rho‑associated protein kinase‑1, and matrix metalloproteinase‑2 and‑9 in HepG2 cells. In addition, the phosphorylation of p38 mitogen‑activated protein kinase and extracellular signal‑regulated kinase 1/2, but not C‑Jun N‑terminal kinase 1/2, was regulated in a dose‑dependent manner in response to zerumbone treatment. The results of the current study indicate that zerumbone could be used as potential anticancer agent in for the treatment of hepatoma in the future.
View Figures
View References

Related Articles

Journal Cover

May-2018
Volume 15 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lv T, Zhang W and Han X: Zerumbone suppresses the potential of growth and metastasis in hepatoma HepG2 cells via the MAPK signaling pathway. Oncol Lett 15: 7603-7610, 2018
APA
Lv, T., Zhang, W., & Han, X. (2018). Zerumbone suppresses the potential of growth and metastasis in hepatoma HepG2 cells via the MAPK signaling pathway. Oncology Letters, 15, 7603-7610. https://doi.org/10.3892/ol.2018.8335
MLA
Lv, T., Zhang, W., Han, X."Zerumbone suppresses the potential of growth and metastasis in hepatoma HepG2 cells via the MAPK signaling pathway". Oncology Letters 15.5 (2018): 7603-7610.
Chicago
Lv, T., Zhang, W., Han, X."Zerumbone suppresses the potential of growth and metastasis in hepatoma HepG2 cells via the MAPK signaling pathway". Oncology Letters 15, no. 5 (2018): 7603-7610. https://doi.org/10.3892/ol.2018.8335